Entering text into the input field will update the search result below

Sierra Oncology, Inc. (SRRA) Nick Glover on Q4 2019 Results - Earnings Call Transcript

Mar. 03, 2020 12:38 PM ETGSK plc (GSK) Stock
SA Transcripts profile picture
SA Transcripts

Sierra Oncology, Inc. (SRRA) Q4 2019 Earnings Conference Call March 3, 2020 8:00 AM ET

Company Participants

Nick Glover - President and Chief Executive Officer

Mark Kowalski - Chief Medical Officer

Barbara Klencke - Chief Development Officer

Sukhi Jagpal - Chief Financial Officer

Conference Call Participants

Maury Raycroft - Jefferies

Sam Slutsky - LifeSci Capital


Good day ladies and gentlemen and welcome to the Sierra Oncology Year End 2019 and 2020 Outlook and Analyst and Investor Call. For your information, this conference is being recorded.

At this time, I'll turn the call over to your host today Nick Glover. Please go ahead sir.

Nick Glover

Thank you. Good morning everybody. I'm Dr. Nick Glover, President and CEO of Sierra Oncology. Thank you very much for joining us today for our 2019 year end result and 2020 outlook conference call.

Joining me today are Dr. Barbara Klencke, our Chief Development Officer; Dr. Mark Kowalski, our Chief Medical Officer; Mr. Sukhi Jagpal, our CFO; and Mr. James Smith, our Vice President, Corporate Affairs.

Today, we reported on financial and operational results for the fourth quarter and year ended December 31st, 2019. Copies of our 10-K and press release and available on our website.

Before we begin today, I do have to point you to our Safe Harbor statement. We are a publicly-traded NASDAQ listed company and subject to all of the rules and regulations, risks, uncertainties, and assumptions that are associated with being a public company. We encourage you to review our regulatory filing and in particular, the risk factors that we update from time-to-time that are contained within those filings, which could cause actual results to differ materially from those described in any forward-looking statements.

Sierra undertakes no obligation to update any forward looking statements to reflect events or circumstances

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About GSK

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on GSK

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.